{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T15:30:29Z","timestamp":1782055829871,"version":"3.54.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"DOI":"10.7759\/cureus.39242","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:16:48Z","timestamp":1684541808000},"source":"Crossref","is-referenced-by-count":2,"title":["Linezolid and Ciprofloxacin-Induced SJS\/TEN (Stevens-Johnson Syndrome\/Toxic Epidermolysis Necrosis) Overlap in a Patient With Borderline Personality Disorder During a Single Hospital Stay: A Difficult Case to Manage"],"prefix":"10.7759","author":[{"given":"Shafia","family":"Memon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Nasir Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Zahoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch M","year":"2018","unstructured":"Lerch M, C. Mainetti C, Picolli T B, Harr T. Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis. Clin Rev Allergy Immunol. 2018, 54:147-76. 10.1007\/s12016-017-8654-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0733-8635(02)00062-1","article-title":"Oral manifestations of erythema multiforme","volume":"21","author":"Ayangco L","year":"2003","unstructured":"Ayangco L, Rogers RS 3rd. Oral manifestations of erythema multiforme. Dermatol Clin. 2003, 21:195-205. 10.1016\/s0733-8635(02)00062-1","journal-title":"Dermatol Clin"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin S","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993, 129:92-6.","journal-title":"Arch Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management","volume":"26","author":"Chang YS","year":"2007","unstructured":"Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea. 2007, 26:123-9. 10.1097\/ICO.0b013e31802eb264","journal-title":"Cornea"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.09.029","article-title":"Toxic epidermal necrolysis: review of pathogenesis and management","volume":"66","author":"Downey A","year":"2012","unstructured":"Downey A, Jackson C, Harun N, Cooper A. Toxic epidermal necrolysis: review of pathogenesis and management. J Am Acad Dermatol. 2012, 66:995-1003. 10.1016\/j.jaad.2011.09.029","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(03)00478-x","article-title":"Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug","volume":"49","author":"H\u00e4llgren J","year":"2003","unstructured":"H\u00e4llgren J, Tengvall-Linder M, Persson M, Wahlgren CF. Stevens-Johnson syndrome associated with ciprofloxacin: a review of adverse cutaneous events reported in Sweden as associated with this drug. J Am Acad Dermatol. 2003, 49:S267-9. 10.1016\/s0190-9622(03)00478-x","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/106002809302701212","article-title":"Ciprofloxacin-induced toxic epidermal necrolysis","volume":"27","author":"Moshfeghi M","year":"1993","unstructured":"Moshfeghi M, Mandler HD. Ciprofloxacin-induced toxic epidermal necrolysis. Ann Pharmacother. 1993, 27:1467-9. 10.1177\/106002809302701212","journal-title":"Ann Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3827","article-title":"Ciprofloxacin-induced Stevens-Johnson syndrome with grapefruit juice consumption: a case report","volume":"11","author":"Cravens MG","year":"2019","unstructured":"Cravens MG, Sherman N, Sawaya J. Ciprofloxacin-induced Stevens-Johnson syndrome with grapefruit juice consumption: a case report. Cureus. 2019, 11:e3827. 10.7759\/cureus.3827","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.22514\/SV92.112014.11","article-title":"Toxic epidermal necrolysis after linezolid administration: case report","volume":"9","author":"Ivi\u0107 D","year":"2014","unstructured":"Ivi\u0107 D, Marjanovi\u0107 K, Ivi\u0107 J, Do\u0161en G. Toxic epidermal necrolysis after linezolid administration: case report. Signa Vitae. 2014, 9:65-7. 10.22514\/SV92.112014.11","journal-title":"Signa Vitae"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.04.082","article-title":"Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"85","author":"Duplisea MJ","year":"2021","unstructured":"Duplisea MJ, Roberson ML, Chrisco L, Strassle PD, Williams FN, Ziemer CM. Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome\/toxic epidermal necrolysis. J Am Acad Dermatol. 2021, 85:873-7. 10.1016\/j.jaad.2021.04.082","journal-title":"J Am Acad Dermatol"},{"key":"ref11","article-title":"An analysis of drug induced Stevens-Johnson syndrome","volume":"136","author":"Patel PP","year":"2012","unstructured":"Patel PP, Gandhi AM, Desai CK, Desai MK, Dikshit RK. An analysis of drug induced Stevens-Johnson syndrome. Indian J Med Res. 2012, 136:1051-3.","journal-title":"Indian J Med Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif A","year":"2004","unstructured":"Nassif A, Bensussan A, Boumsell L, et al.. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol. 2004, 114:1209-15. 10.1016\/j.jaci.2004.07.047","journal-title":"J Allergy Clin Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt M","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, et al.. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008, 128:35-44. 10.1038\/sj.jid.5701033","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-209102","article-title":"Toxic epidermal necrolysis with the use of tamoxifen","volume":"2015","author":"Madabhavi I","year":"2015","unstructured":"Madabhavi I, Revannasiddaiah S, Patel A, Anand A. Toxic epidermal necrolysis with the use of tamoxifen. BMJ Case Rep. 2015, 2015:3-7. 10.1136\/bcr-2014-209102","journal-title":"BMJ Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz RA","year":"2013","unstructured":"Schwartz RA, McDonough PH, Lee BW. Toxic epidermal necrolysis: part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol. 2013, 69:187.e1-16. 10.1016\/j.jaad.2013.05.002","journal-title":"J Am Acad Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung WH","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS, et al.. Medical genetics: a marker for Stevens-Johnson syndrome. Nature. 2004, 428:486. 10.1038\/428486a","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.10.015","article-title":"Drug-induced epidermal necrolysis: Important new piece to end the puzzle","volume":"128","author":"Roujeau JC","year":"2011","unstructured":"Roujeau JC, Bricard G, Nicolas JF. Drug-induced epidermal necrolysis: Important new piece to end the puzzle. J Allergy Clin Immunol. 2011, 128:1277-8. 10.1016\/j.jaci.2011.10.015","journal-title":"J Allergy Clin Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200001060-00003","article-title":"Drug-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"1","author":"Fritsch PO","year":"2000","unstructured":"Fritsch PO, Sidoroff A. Drug-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis. Am J Clin Dermatol. 2000, 1:349-60. 10.2165\/00128071-200001060-00003","journal-title":"Am J Clin Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5114\/pdia.2014.40796","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis presumably induced by norfloxacin","volume":"31","author":"Maciejewska J","year":"2014","unstructured":"Maciejewska J, Jankowski M, Zegarska B, Czajkowski R. Stevens-Johnson syndrome\/toxic epidermal necrolysis presumably induced by norfloxacin. Postepy Dermatol Alergol. 2014, 31:194-6. 10.5114\/pdia.2014.40796","journal-title":"Postepy Dermatol Alergol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.21276\/ijppdr.2019.9.2.7","article-title":"Topiramate induced Stevens-Johnsons syndrome (SJS)-a case report","volume":"9","author":"Kamila S","year":"2019","unstructured":"Kamila S, Katla S. Topiramate induced Stevens-Johnsons syndrome (SJS)-a case report. Int J Pharm Pract Drug Res. 2019, 9:46-9. 10.21276\/ijppdr.2019.9.2.7","journal-title":"Int J Pharm Pract Drug Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/135580-linezolid-and-ciprofloxacin-induced-sjsten-stevens-johnson-syndrometoxic-epidermolysis-necrosis-overlap-in-a-patient-with-borderline-personality-disorder-during-a-single-hospital-stay-a-difficult-case-to-manage","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:41Z","timestamp":1707508901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/135580-linezolid-and-ciprofloxacin-induced-sjsten-stevens-johnson-syndrometoxic-epidermolysis-necrosis-overlap-in-a-patient-with-borderline-personality-disorder-during-a-single-hospital-stay-a-difficult-case-to-manage"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.39242","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}